ANÁLISE DO PERFIL EPIDEMIOLÓGICO DAS PACIENTES JOVENS DIAGNOSTICADAS COM CÂNCER DE MAMA EM UM HOSPITAL DE REFERÊNCIA NA PARAÍBA

Abstract

Although breast cancer occurs predominantly after 40 years of age, it can affect young women, usually presenting more aggressive behavior. Younger women with the diagnosis have a worse prognosis and higher mortality compared to older women. Objective: In this study, we examined the epidemiological profile of young women with breast cancer Methodology: This is an observational and cross-sectional study, carried out between August 2020 and July 2021 based on the application of forms. A survey was carried out at the Mastology service of Hospital Napoleão Laureano, João Pessoa-PB. Data were collected from the medical records of 77 patients. Collecting the collection, all data collected in the questionnaires were registered and tabulated in an Excel spreadsheet, with the mean, mode and median being performed. Results: The age at diagnosis ranged between 25 and 40 years, with a predominance of patients (76.7%) aged over or equal to 30 years. The mean age was 33.5 years, the median 3 and the mode 35 years. Most patients are single (48.1%), brown (68.4%), have 1 child (43.2%), live in the interior of Paraíba (61.8%), with higher or secondary education. complete (62.5%), housewife (20%) and overweight or obese (53.7%). The use of oral contraceptives was confirmed by 41 patients 61 among (67.2%). The mean age at menarche was 12.3 years. Most patients continue menstruating (56.6%). Of 54 patients, 12 have at least one risk factor. Family history of breast cancer was applied by 21 patients out of 61 (34.4%). Of 56 patients, only 3 had a history of another personal cancer. Conclusion: Breast cancer in young patients is an important public health problem. It is essential to evaluate the presence or absence of factors that may influence the appearance of breast cancer in women in this age group, thus requiring an understanding of the epidemiological profile, aiming that the patient obtains the minimization of modifiable risk factors, an early diagnosis and the maximum benefit from your treatment.